Want to see DE:93M1 full AI Analyst Report?
93M1 Stock Chart & Stats
€25.10
-€0.40(-1.66%)
At close: 4:00 PM EDT
€25.10
-€0.40(-1.66%)
Day’s Range― - ―
52-Week Range€17.45 - €29.70
Previous CloseN/A
Volume1.24K
Average Volume (3M)1.59K
Market Cap
€120.74M
Enterprise Value€141.07M
Total Cash (Recent Filing)€2.82M
Total Debt (Recent Filing)€15.37M
Price to Earnings (P/E)1.1
Beta0.66
Next Earnings
Nov 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield17.73%
Share Statistics
EPS (TTM)25.01
Shares Outstanding4,281,384
10 Day Avg. Volume1,440
30 Day Avg. Volume1,586
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio765.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.7
Revenue Forecast (FY)€41.20M
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low debt relative to equity gives MPH substantial financial flexibility and reduces interest and refinancing pressure. This conservative structure can help the company withstand volatility in portfolio values while preserving capacity to manage or develop healthcare investments over the medium term.
Returned ProfitabilityA return to consistent positive earnings since 2022, including an approximately 8% net margin in 2025, indicates improved profitability compared with earlier losses. If maintained, this provides a stronger base for distributions, reinvestment, and continued portfolio management.
Healthcare Portfolio ExposureExposure to both pharmaceuticals and healthcare services gives MPH a healthcare-focused investment platform rather than reliance on a single operating product. Managing interests across these areas may provide multiple avenues for long-term value creation as underlying holdings develop.
Bears Say
Highly Erratic RevenueSharp revenue swings make it difficult to establish a dependable growth trajectory or forecast earnings power. For a holding company, uneven investment-related income can reduce confidence in recurring performance and complicate decisions on distributions, reinvestment, and portfolio development.
Weak Cash ConversionVolatile operating and free cash flow, including another sharp decline in 2025, weakens confidence that reported earnings consistently convert into cash. Limited cash generation can constrain self-funding capacity and make distributions or new investments less dependable over the next several quarters.
Portfolio-market DependenceBecause MPH earns primarily from dividends, distributions, investment-value changes, and realized gains, results depend heavily on the performance and valuation of its underlying holdings. This can make earnings less predictable than those of a company with recurring operating revenue.
93M1 FAQ
What was MPH Health Care AG’s price range in the past 12 months?
MPH Health Care AG lowest stock price was €17.45 and its highest was €29.70 in the past 12 months.
What is MPH Health Care AG’s market cap?
MPH Health Care AG’s market cap is €120.74M.
When is MPH Health Care AG’s upcoming earnings report date?
MPH Health Care AG’s upcoming earnings report date is Nov 25, 2026 which is in 36 days.
How were MPH Health Care AG’s earnings last quarter?
MPH Health Care AG released its earnings results on Sep 16, 2026. The company reported €1.169 earnings per share for the quarter.
Is MPH Health Care AG overvalued?
According to Wall Street analysts MPH Health Care AG’s price is currently Overvalued.
Does MPH Health Care AG pay dividends?
MPH Health Care AG pays a Annually dividend of €5 which represents an annual dividend yield of 17.73%. See more information on MPH Health Care AG dividends here
What is MPH Health Care AG’s EPS estimate?
MPH Health Care AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MPH Health Care AG have?
MPH Health Care AG has 4,281,384 shares outstanding.
What happened to MPH Health Care AG’s price movement after its last earnings report?
MPH Health Care AG reported an EPS of €1.169 in its last earnings report. Following the earnings report the stock price went down -0.733%.
Which hedge fund is a major shareholder of MPH Health Care AG?
Currently, no hedge funds are holding shares in DE:93M1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MPH Health Care AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.47%
12-Months-Change
Fundamentals
Return on Equity
43.53%
Trailing 12-Months
Asset Growth
21.86%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
MPH Health Care AG
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and various other chronic conditions. Beyond pharmaceuticals, it also delivers medical aesthetic treatments, develops and markets a diverse array of pharmaceutical and medical items, and furnishes related services and specialized medical devices for use in aesthetic surgery and cosmetic dermatology. Furthermore, its operations extend to supplying cytostatic solutions and involvement in real estate ventures. Established in Berlin in 2008, the company adopted its current name, MPH Health Care AG, in 2017, having previously been known as MPH Mittelständische Pharma Holding AG. It functions as a subsidiary of Magnum AG.